PL EN


Preferences help
enabled [disable] Abstract
Number of results
2013 | 25 | 100 | 112-118
Article title

SELECTIVE SEROTONIN REUPTAKE INHIBITORS – MEDICATIONS NOT ONLY FOR DEPRESSION

Content
Title variants
Languages of publication
EN
Abstracts
EN
Selective serotonin reuptake inhibitors (SSRIs) are the frontline class of antidepressant drugs. They are widely used because of their safety, tolerability, and demonstrated efficacy. In this review, we are pointing at other indications of SSRIs – apart from depression.This article is based on a selective review of the relevant literature retrieved by a PubMed search and ScienceDirect search. The results of electronic searches show SSRIs to be of great importance in pharmacotherapy of many conditions outside depression. Medical literature supports the use of SSRIs for the treatment of premature ejaculation (especially short-acting SSRI - dapoxetine), eating disorders (especially bulimia nervosa and binge eating disorder), obsessive-compulsive disorder and social anxiety disorder.
Year
Volume
25
Issue
100
Pages
112-118
Physical description
Contributors
author
  • Department of Pharmacological Screening, Chair of Pharmacodynamic Faculty of Pharmacy, Medical College, Jagiellonian University, Medyczna 9, 30-688 Kraków, Poland
References
Document Type
article
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.psjd-98c5115f-c383-4ee0-a3b1-3c629e1ab171
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.